We are live on ! Find out more

2,537 hedge funds and large institutions have $175B invested in Merck in 2019 Q4 according to their latest regulatory filings, with 331 funds opening new positions, 1,006 increasing their positions, 930 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

394% more first-time investments, than exits

New positions opened: 331 | Existing positions closed: 67

11% more funds holding in top 10

Funds holding in top 10: 188208 (+20)

10% more funds holding

Funds holding: 2,3062,537 (+231)

8% more capital invested

Capital invested by funds: $162B → $175B (+$13.2B)

8% more repeat investments, than reductions

Existing positions increased: 1,006 | Existing positions reduced: 930

0.31% more ownership

Funds ownership: 78.98%79.29% (+0.31%)

18% less call options, than puts

Call options by funds: $1.62B | Put options by funds: $1.98B

Holders
2,537
Holders Change
+231
Holders Change %
+10.02%
% of All Funds
49.98%
Holding in Top 10
208
Holding in Top 10 Change
+20
Holding in Top 10 Change %
+10.64%
% of All Funds
4.1%
New
331
Increased
1,006
Reduced
930
Closed
67
Calls
$1.62B
Puts
$1.98B
Net Calls
-$358M
Net Calls Change
-$73.8M
Name Holding Trade Value Shares
Change
Change in
Stake
PAG
376
Private Advisor Group
New Jersey
$26.7M -$779K -9,479 -3%
MAM
377
Madison Asset Management
Wisconsin
$26.7M +$25.3M +307,536 New
Impax Asset Management Group
378
Impax Asset Management Group
United Kingdom
$26.6M +$1.53M +18,582 +6%
CPSAC
379
Chas P. Smith & Associates (CPS)
Florida
$26.6M -$507K -6,169 -2%
ISL
380
Ingalls & Snyder LLC
New York
$26.4M -$82.5K -1,005 -0.3%
PNC
381
Park National Corp
Ohio
$26.4M -$1.53M -18,662 -6%
ELI
382
Empire Life Investments
Ontario, Canada
$26.3M +$142K +1,726 +0.6%
OC
383
Oppenheimer & Co
New York
$25.9M -$890K -10,839 -4%
TCA
384
Transcend Capital Advisors
New Jersey
$25.9M +$24.5M +298,365 New
DCM
385
Dupont Capital Management
Delaware
$25.8M +$528K +6,423 +2%
RMDI
386
R.M. Davis Inc
Maine
$25.7M +$185K +2,257 +0.8%
A
387
AustralianSuper
Australia
$25.3M +$1.42M +17,241 +6%
HCMNY
388
Howard Capital Management (New York)
New York
$25.3M +$53.4K +650 +0.2%
AHB
389
Abner Herrman & Brock
New Jersey
$24.8M -$2.05M -24,942 -8%
II
390
IFM Investors
Australia
$24.7M -$617K -7,507 -3%
FMLI
391
Fukoku Mutual Life Insurance
Japan
$24.5M +$170K +2,065 +0.7%
RJT
392
Raymond James Trust
Florida
$24.4M +$738K +8,988 +3%
CIM
393
Corda Investment Management
Texas
$24.2M -$351K -4,275 -2%
CCMD
394
Cypress Capital Management (Delaware)
Delaware
$24M -$77.9K -949 -0.3%
VDI
395
Vaughan David Investments
Illinois
$24M +$924K +11,245 +4%
Wolverine Trading
396
Wolverine Trading
Illinois
$23.9M +$14.7M +178,864 +185%
SI
397
Stephens Inc
Arkansas
$23.8M -$197K -2,400 -0.9%
Fidelity International
398
Fidelity International
Bermuda
$23.8M -$50.4M -613,538 -69%
B
399
BP
United Kingdom
$23.7M +$86.1K +1,048 +0.4%
BAM
400
Berkshire Asset Management
Pennsylvania
$23.7M -$762K -9,274 -3%

MRK Hedge Fund Activity: Q4 2019 in Review

2,537 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2019, worth a combined $175B — up 8.1% from $162B a quarter earlier.

Buyers outnumbered sellers: 331 funds opened new MRK positions and 67 closed out — a net gain of 264 holders — while 1,006 added to existing stakes and 930 trimmed.

The largest buyer was BlackRock, adding an estimated $403M. The largest seller was Capital World Investors, cutting an estimated $1.61B.

  • 2,537 institutional investors held Merck (MRK) as of Q4 2019, up from 2,306 in Q3 2019.
  • Funds reported $175B of Merck stock for Q4 2019, up 8.1% quarter-over-quarter.
  • 331 funds opened new Merck positions in Q4 2019 and 67 closed out, a net change of +264 holders.
  • The largest Merck buyer in Q4 2019 was BlackRock, an estimated $403M added.
  • The largest Merck seller in Q4 2019 was Capital World Investors, an estimated $1.61B sold.

Based on aggregated 13F filings for Q4 2019.